In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Leyva Peralta, Alberto ^a   Robles Zepeda, Enrique ^a   Garibay Escobar, Adriana ^a   Ruiz Bustos, Eduardo ^a   Alvarez Berber, Patricia ^b   Gálvez Ruiz, Carlos ^a  

^a UNIVERSIDAD DE SONORA   (Mexico)

^b CENTRO DE INVESTIGACIONES QUÍMICAS   (Mexico)

Author keywords

Alkaloids; Anti proliferative activity; Argemone gracilenta; Cancer cells; Fatty acids; MTT

Indexed keywords

7 OCTADECENOIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; ARGEMONE GRACILENTA EXTRACT; ARGEMONINE; BERBERINE; HEXADECANOIC ACID ETHYL ESTER; HEXADECANOIC ACID METHYL ESTER; LINOLEIC ACID; LINOLEIC ACID ETHYL ESTER; PALMITIC ACID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; ALKALOID; FATTY ACID; FUSED HETEROCYCLIC RINGS; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARGEMONE; ARGEMONE GRACILENTA; ARTICLE; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CONTROLLED STUDY; DRUG IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS FRAGMENTOGRAPHY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; ANIMAL; CELL LINE; CHEMISTRY; FEMALE; HELA CELL LINE; ISOLATION AND PURIFICATION; MOUSE; PHYTOTHERAPY; UTERINE CERVICAL NEOPLASMS;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARGEMONE; BERBERINE; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE; FATTY ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HELA CELLS; HUMANS; IN VITRO TECHNIQUES; MICE; PHYTOTHERAPY; PLANT EXTRACTS; TETRAHYDROISOQUINOLINES; UTERINE CERVICAL NEOPLASMS;

EID: 84924285180     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0532-8     Document Type: Article

References (36)

1. Fadeyi SA, Fadeyi OO, Adejumo AA, Okoro C, Myles EL. In vitro anticancer screening of 24 locally used Nigerian medicinal plants. BMC Complement Altern Med. 2013;13(79):1-9.
2. Umthong S, Phuwapraisirisan P, Puthung S, Chanchao C. In vitro antiproliferative activity of partially purified Trigona leaviceps propolis from Thailand on human cancer cell lines. BMC Complement Altern Med. 2011;11(37):1-8.
3. Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, et al. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med. 2011;6(27):1-15.
4. Alonso-Castro AJ, Villarreal ML, Salazar-Olivo LA, Gomez-Sanchez M, Dominguez F, Garcia-Carranca A. Mexican medicinal plants used for cancer treatment: pharmacological, phytochemical and ethnobotanical studies. J Ethnopharmacol. 2011;133:945-72.
5. Ma X, Wang Z. Anticancer drug discovery in the future: an evolutionary perspective. Drug Discov Today. 2009;14(23/24):1136-42.
6. Gumenyuk VG, Bashmakova NV, Kutovyy SY, Yashchuk VM, Zaika LA. Binding parameter of alkaloids berberine and sanguinarine with DNA. Ukr J Phys. 2011;56(6):524-33.
7. Kim J, Park EJ. Cytotoxic anticancer candidates from natural resources. Curr Med Chem-Anti-cancer. 2002;2(4):485-537.
8. Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer. 2002;2(2):143-8.
9. McChesney JD, Venkataraman SK, Henri JT. Plant natural products: back to the future or into extinction? Phytochemestry. 2007;68:2015-22.
10. Lin YC, Wang CC, Chen IS, Jheng JL, Li JH, Tung CW. TIPdb: a database of anticancer, antiplatelet, and antituberculosis phytochemicals from indigenous plants in Taiwan. Sci World J. 2013;2013:1-4.
11. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100:72-9.
12. Sanchez-Mendoza ME, Castillo-Henkel C, Navarrete A. Relaxant action mechanism of berberine identified as the active priciple of Argemone ochroleuca Sweet in guinea-pig tracheal smooth muscle. Pharm Pharmacol. 2008;60:229-36.
13. Kiranmayi G, Ramakrishnani G, Kothai R, Jaykar B. In vitro anti-cancer of methanolic extract of leaves of Argemone Mexicana Linn. Int J PharmTech Res. 2011;13(3):1329-33.
14. Bhattacharjee I, Chatterjee SK, Chatterjee S, Chandra G. Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria. Mem Inst Oswaldo Cruz. 2006;110(6):645-8.
15. Apu AS, AL-Baizyd AH, Ara F, Bhuyan SH, Matin M, Hossain F. Phytochemical analysis and bioactivities of Argemone mexicana Linn. Leaves PharmacolOnLine. 2012;3:16-23.
16. Yuh-Chwen C, Fang-Rong C, Ashraf TK, Pei-Wen H, Yang-Chang W. Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana. Z Naturforsch C. 2003;57:521-6.
17. Stermitz FR, McMurtrey KD. Alkaloids of the Papaveraceae X New alkaloids from Argemone gracilenta Greene. J Org Chem. 1968;34(3):555-9.
18. Ruiz-Bustos E, Velazquez C, Garibay-Escobar A, García Z, Plascencia-Jatomea M, Cortez-Rocha MO, et al. Antibacterial and antifungal activities of some mexican medicinal plants. J Med Food. 2009;12:1398-402.
19. Shakirov R, Telezhenetskaya MV, Bessonova IA, Aripova SF, Israilov IA, Soltankhodzhaev MN, et al. Alkaloids. plants, structure, properties. Chem Nat Compd. 1996;32:216-334.
20. Velazquez C, Navarro M, Acosta A, Angulo A, Dominguez Z, Robles R, et al. Antibacterial and free- radical scavenging activities on Sonoran propolis. J Appl Microbiol. 2007;103:1747-56.
21. Suffness M, Pezzuto JM. Assays related to cancer drug discovery. In: Hostettmann K, editor. Methods in Plant Biochemistry. In: Assays for Bioactivity. London: 6: Academic Press; 1990. p. 71-133.
22. Shabana MM, Salama MM, Shahira M, Ismail LR. In Vitro and In Vivo anticancer activity of the fruit peels of Solanum melongena L. against hepatocellular carcinoma. J Carcinog Mutagen. 2013;4(3):1-6.
23. Boik J. Natural Compounds in Cancer Therapy. Minnesota, USA: Oregon Medical Press, Princeton; 2001. p. 25.
24. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907-16.
25. Youte J, Barbier D, Gnecco D, Marazano C. An enantioselective acess to 1-alkalyl-1,2,3,4-tetrahydroisoquinolines. Application to a new synthesis of (-)-argemonine. J Org Chem. 2004;69(8):2737-40.
26. Blasko G, Cordell G, Bhamaraparavati S, Beecher C. Carbon-13 NMR assignments of berberine and sanguinarina. Heterocycles. 1988;27(4):911-6.
27. Fernández, J: Estudio químico biodirigido de la actividad antiasmática de Argemone platyceras. PhD thesis, Universidad Autónoma Metropolitana, Distrito Federal, México; 2005. http://148.206.53.84/tesiuami/UAMI12769.pdf. Accessed August 2014.
28. Slaninová I, Pencíková K, Urbanová K, Slanina J, Táburská E. Antitumor activities of sanguinarine and related alkaloids. Phytochemistry Rev. 2013;13:1-9.
29. Jin-Jian L, Jiao-Lin B, Xiu-Ping C, Huang Mand M, Wang Y. Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Alternative Med. 2012;2012:1-12.
30. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. 2006;5(2):296-308.
31. Eom KS, Kim HJ, So S, Park R, Kim TY. Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol Pharm Bull. 2010;3(10):1644-9.
32. Sun XY, Wang K, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer Drugs. 2009;20(9):757-69.
33. Ho Y, Yang J, Li T. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitors of FAK, IKK, NF-kB, u-PA and MMP-2 and -9. Cancer Lett. 2009;279(2):155-62.
34. Hamsa T, Kuttan G. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug Chem Toxicol. 2012;35(1):57-70.
35. Girao LA, Rock AC, Cantrill RC, Davidson BC. The effect of C18 fatty acids on cancer cells in culture. Anticancer Res. 1986;6(2):241-4.
36. Huges-Fulford M, Chen Y, Tjandrawinata R. Fatty acid regulates gene expression and growth of human prostate cancer PC-3. Carcinog. 2001;22(5):701-7.